The invention provides an application of a reagent for losing CTTNBP2NL function in preparation of a medicine for treating diseases. Mainly provides an application of a reagent for losing CTTNBP2NL function in preparation of drugs for treating diseases caused by STAT3 protein phosphorylation. The reagent for deleting the CTTNBP2NL function is a reagent for inhibiting the expression of the CTTNBP2NL or a reagent for inhibiting the promotion of the phosphorylation activity of STAT3 protein in tumor cells by the CTTNBP2NL. Overexpression of CTTNBP2NL can cause the occurrence of diseases. The function of CTTNBP2NL is lost, so that phosphorylation of the STAT3 protein Y705 site in tumor cells can be effectively reduced, and tumor growth is inhibited; meanwhile, the function of CTTNBP2NL is lost, so that the generation of autoantibodies can be reduced, and systemic lupus erythematosus can be treated; the traditional Chinese medicine composition can also relieve the symptoms of rheumatic arthritis, inflammatory bowel disease, psoriasis and the like, and effectively treat rheumatic arthritis, inflammatory bowel disease, psoriasis and the like. Therefore, the CTTNBP2NL function-deficient reagent can be used for medicines for treating tumors, autoimmune diseases and neurological diseases, and has a good application prospect.